Glycan Therapeutics
Pre-clinicalDevelops glycan-based therapeutics and vaccines for cancer and infectious diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $4.5M
About
Develops glycan-based therapeutics and vaccines for cancer and infectious diseases.
BiologicsOncologyInfectious Disease
Funding History
2Total raised:$4.5M
Seed$4MFeb 15, 2021
Grant$500KApr 15, 2018